EMEA-000876-PIP03-14-M03

Key facts

Invented name
Soliris
Active substance
Eculizumab
Therapeutic area
Neurology
Decision number
P/0252/2019
PIP number
EMEA-000876-PIP03-14-M03
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of neuromyelitis optica spectrum disorders
Route(s) of administration
Intravenous use
Contact for public enquiries
Alexion Europe SAS

Tel. +33 1 4710 0615
E-mail: pip.enquiries.eu@alexion.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating